Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	p53 binding	RFFL TRIM24 CREBBP HTT TP73	5.10e-05	77	104	5	GO:0002039
GeneOntologyMolecularFunction	NuRD complex binding	PWWP2A ZNF827	8.03e-05	3	104	2	GO:0120325
GeneOntologyMolecularFunction	TFIIB-class transcription factor binding	TCF4 CREBBP	3.98e-04	6	104	2	GO:0001093
GeneOntologyBiologicalProcess	semicircular canal development	GATA2 EYA1 GLI3	1.94e-05	11	103	3	GO:0060872
HumanPheno	Motor stereotypy	SOX5 TCF4 TCF20 CEP85L HUWE1 CREBBP SYNGAP1 VPS13A MACF1 MBD5 RAI1 HTT	1.61e-07	280	35	12	HP:0000733
HumanPheno	Restricted or repetitive behaviors or interests	SOX5 TCF4 TCF20 CEP85L HUWE1 CREBBP SYNGAP1 VPS13A MACF1 MBD5 RAI1 HTT	3.08e-06	368	35	12	HP:0031432
HumanPheno	Perseverative thought	SOX5 TCF4 TCF20 CEP85L HUWE1 CREBBP SYNGAP1 VPS13A MACF1 MBD5 RAI1 HTT	3.97e-06	377	35	12	HP:0030223
HumanPheno	Disordered formal thought process	SOX5 TCF4 TCF20 CEP85L HUWE1 CREBBP SYNGAP1 VPS13A MACF1 MBD5 RAI1 HTT	5.08e-06	386	35	12	HP:0025769
HumanPheno	Abnormal thought pattern	SOX5 TCF4 TCF20 CEP85L HUWE1 CREBBP SYNGAP1 VPS13A MACF1 MBD5 RAI1 HTT	8.17e-06	404	35	12	HP:5200269
HumanPheno	Myopia	SOX5 TCF4 TCF20 TTLL5 HUWE1 CREBBP USF3 MBD5 CSPP1 AFF4 RAI1 HTT	2.31e-05	447	35	12	HP:0000545
HumanPheno	Sleep abnormality	TET2 TCF4 DMXL2 TCF20 HUWE1 CREBBP SYNGAP1 PER3 VPS13A MBD5 AFF4 RAI1 HTT	8.60e-05	596	35	13	HP:0002360
HumanPheno	Cupped ear	TCF4 EYA1 HUWE1 MBD5 AFF4	9.33e-05	69	35	5	HP:0000378
HumanPheno	Overlapping toe	SOX5 TCF4 HUWE1 CREBBP GLI3	1.14e-04	72	35	5	HP:0001845
HumanPheno	Poor coordination	TCF20 HUWE1 CREBBP SYNGAP1	1.30e-04	39	35	4	HP:0002370
HumanPheno	Renal dysplasia	DMXL2 EYA1 ITGB4 GLI3 CSPP1	1.30e-04	74	35	5	HP:0000110
Domain	PHD	TCF20 MLLT10 TRIM24 TRIM33 RAI1	1.27e-04	89	102	5	SM00249
Domain	Znf_PHD	TCF20 MLLT10 TRIM24 TRIM33 RAI1	1.41e-04	91	102	5	IPR001965
Domain	ZF_PHD_2	TCF20 MLLT10 TRIM24 TRIM33 RAI1	1.73e-04	95	102	5	PS50016
Domain	ZF_PHD_1	TCF20 MLLT10 TRIM24 TRIM33 RAI1	1.81e-04	96	102	5	PS01359
Domain	EPHD	TCF20 MLLT10 RAI1	2.26e-04	22	102	3	PS51805
Domain	SEA	MUC16 MUC12 MUC17	2.26e-04	22	102	3	PF01390
Domain	SEA	MUC16 MUC12 MUC17	2.59e-04	23	102	3	PS50024
Domain	SEA_dom	MUC16 MUC12 MUC17	2.59e-04	23	102	3	IPR000082
Domain	UBA-like	TAB2 TNRC6C HUWE1 SPATS2L	4.14e-04	64	102	4	IPR009060
Domain	Alpha_kinase	ALPK3 ALPK2	4.37e-04	6	102	2	PF02816
Domain	MHCK_EF2_kinase	ALPK3 ALPK2	4.37e-04	6	102	2	IPR004166
Domain	ALPHA_KINASE	ALPK3 ALPK2	4.37e-04	6	102	2	PS51158
Domain	Alpha_kinase	ALPK3 ALPK2	4.37e-04	6	102	2	SM00811
Domain	UBA	TNRC6C HUWE1 MARK4	5.77e-04	30	102	3	SM00165
Domain	UBA	TNRC6C HUWE1 MARK4	9.91e-04	36	102	3	PF00627
Domain	BROMODOMAIN_1	TRIM24 CREBBP TRIM33	1.07e-03	37	102	3	PS00633
Domain	Bromodomain	TRIM24 CREBBP TRIM33	1.16e-03	38	102	3	PF00439
Domain	Znf_FYVE_PHD	TCF20 RFFL MLLT10 TRIM24 TRIM33	1.27e-03	147	102	5	IPR011011
Domain	EF-hand_4	REPS1 EPS15L1	1.29e-03	10	102	2	PF12763
Domain	PTB	DAB2 TNS1 GULP1	1.35e-03	40	102	3	SM00462
Domain	PTB/PI_dom	DAB2 TNS1 GULP1	1.45e-03	41	102	3	IPR006020
Domain	BROMODOMAIN_2	TRIM24 CREBBP TRIM33	1.45e-03	41	102	3	PS50014
Domain	Bromodomain	TRIM24 CREBBP TRIM33	1.56e-03	42	102	3	IPR001487
Domain	BROMO	TRIM24 CREBBP TRIM33	1.56e-03	42	102	3	SM00297
Domain	-	TRIM24 CREBBP TRIM33	1.56e-03	42	102	3	1.20.920.10
Domain	EH	REPS1 EPS15L1	1.57e-03	11	102	2	PS50031
Domain	EH	REPS1 EPS15L1	1.57e-03	11	102	2	SM00027
Domain	EH_dom	REPS1 EPS15L1	1.57e-03	11	102	2	IPR000261
Domain	UBA	TNRC6C HUWE1 MARK4	1.78e-03	44	102	3	IPR015940
Domain	C8	MUC5B MUC6	1.88e-03	12	102	2	PF08742
Domain	TIL	MUC5B MUC6	1.88e-03	12	102	2	PF01826
Domain	UBA	TNRC6C HUWE1 MARK4	2.15e-03	47	102	3	PS50030
Domain	Unchr_dom_Cys-rich	MUC5B MUC6	2.22e-03	13	102	2	IPR014853
Domain	C8	MUC5B MUC6	2.22e-03	13	102	2	SM00832
Domain	TIL_dom	MUC5B MUC6	2.57e-03	14	102	2	IPR002919
Domain	SEA	MUC16 MUC17	2.57e-03	14	102	2	SM00200
Domain	Kinase-like_dom	MAST2 PTK2B KSR1 MARK4 ALPK3 MACF1 PAN3 MAPK6 ALPK2	2.86e-03	542	102	9	IPR011009
Domain	Bbox_C	TRIM24 TRIM33	2.96e-03	15	102	2	IPR003649
Domain	BBC	TRIM24 TRIM33	2.96e-03	15	102	2	SM00502
Domain	-	MUC16 MUC17	2.96e-03	15	102	2	3.30.70.960
Domain	VWF_type-D	MUC5B MUC6	3.37e-03	16	102	2	IPR001846
Domain	VWFD	MUC5B MUC6	3.37e-03	16	102	2	PS51233
Domain	VWD	MUC5B MUC6	3.37e-03	16	102	2	SM00216
Domain	VWD	MUC5B MUC6	3.37e-03	16	102	2	PF00094
Domain	Gal_mutarotase_SF_dom	MAN2A1 MGAM2	3.81e-03	17	102	2	IPR011013
Domain	VWC_out	MUC5B MUC6	4.75e-03	19	102	2	SM00215
Domain	Zinc_finger_PHD-type_CS	MLLT10 TRIM24 TRIM33	5.41e-03	65	102	3	IPR019786
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12 MUC17 MUC6	1.35e-08	16	73	5	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12 MUC17 MUC6	1.91e-08	17	73	5	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12 MUC17 MUC6	1.01e-07	23	73	5	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12 MUC17 MUC6	1.96e-07	26	73	5	M27483
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC17 MUC6	3.71e-06	21	73	4	MM15706
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 TAB2 MUC5B MUC12 CREBBP MUC17 MUC6	7.73e-06	140	73	7	M27484
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC12 MUC17 MUC6	1.67e-05	62	73	5	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 MUC17 MUC6	2.62e-05	68	73	5	M27303
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC17 MUC6	2.59e-04	60	73	4	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC12 MUC17 MUC6	2.71e-04	111	73	5	M27416
Pathway	PID_AR_PATHWAY	TCF4 RANBP9 PIAS1 PTK2B	2.76e-04	61	73	4	M58
Pubmed	A human MAP kinase interactome.	HIVEP1 TCF20 RBBP6 COBLL1 CNTRL RANBP9 DAB2 MUC12 ITPRID2 PIAS1 ITGB4 CREBBP RIF1 USF3 ATF7IP NAV2 MACF1 MAPK6 MBD5 TNS1	3.51e-17	486	106	20	20936779
Pubmed	Human transcription factor protein interaction networks.	SOX5 TET2 TCF4 HIVEP1 ZBTB33 TCF20 RBBP6 ATXN7L1 RBMS1 GATA2 TNRC6C MLLT10 TRIM24 PIAS1 CREBBP TRIM33 RIF1 GSE1 ZFHX4 ZSCAN21 ATF7IP GLI3 TBXT SCAF11 PAN3 MYBL2	1.21e-13	1429	106	26	35140242
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DOCK3 REPS1 GATA2 ANKLE1 TNRC6C HUWE1 MLLT10 MAST2 ITGB4 EPS15L1 ZNF827 MARK4 NAV2 RIPOR1 MAPKBP1 MBD5 BCL2L13 RAI1 HTT MYBL2	1.36e-10	1105	106	20	35748872
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP36 ZBTB33 TTC28 RBBP6 ATXN7L1 RANBP9 MAST2 TRIM24 CREBBP TRIM33 KSR1 GSE1 ZFHX4 ZNF827 GLI3 MARK4 MACF1 AFF4 RAI1 TP73	1.61e-10	1116	106	20	31753913
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TET2 HIVEP1 ZBTB33 TCF20 TRIM24 CREBBP TRIM33 GSE1 ZSCAN21 AFF4 RAI1	6.75e-10	268	106	11	33640491
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MIIP TET2 HIVEP1 TCF20 TTC28 CEP85L COBLL1 TAB2 ITPRID2 MAST2 PTK2B KSR1 MARK4 NAV2 MACF1 PAN3 CSPP1	1.05e-09	861	106	17	36931259
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	USP36 KIF18A TCF20 ATXN7L1 TRIM24 PIAS1 CREBBP TRIM33 AFF4 MYBL2	1.71e-09	222	106	10	37071664
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC5B MUC12 MUC17 MUC6	1.98e-09	18	106	5	18834073
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	HIVEP1 TTC28 RBBP6 TAB2 ITPRID2 HUWE1 PIAS1 CREBBP TRIM33 GSE1 ATF7IP MACF1 TP73 MYBL2	3.40e-09	588	106	14	38580884
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 HIVEP1 ZBTB33 TCF20 TTC28 HUWE1 SOX8 TRIM24 GSE1 ZFHX4 ATF7IP MYBL2	6.18e-09	418	106	12	34709266
Pubmed	Interaction network of human early embryonic transcription factors.	SOX5 TET2 HIVEP1 TCF20 TRIM24 PIAS1 CREBBP TRIM33 GSE1 ZFHX4 RAI1	1.12e-08	351	106	11	38297188
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TET2 TCF4 TNRC6C EYA1 CREBBP SPATS2L GSE1 FAM222B	2.32e-08	152	106	8	38360978
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX5 TCF4 HIVEP1 ZBTB33 TCF20 GATA2 MLLT10 TRIM24 PIAS1 RIF1 PER3 ZSCAN21 GLI3 TBXT MYBL2	2.49e-08	808	106	15	20412781
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	USP36 HIVEP1 ZBTB33 TCF20 RBBP6 RBMS1 TRIM24 TRIM33 RIF1 EPS15L1 ZSCAN21 ATF7IP SCAF11 AFF4 RAI1 MYBL2	3.33e-08	954	106	16	36373674
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SOX5 TCF4 HIVEP1 ZBTB33 TCF20 GATA2 MLLT10 PIAS1 CREBBP ZSCAN21 GLI3 MACF1 TBXT MYBL2	3.54e-08	709	106	14	22988430
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	TCF4 ZBTB33 TCF20 GATA2 MLLT10 SOX8 TRIM24 CREBBP FOSL1 ZSCAN21 GLI3 RAI1 TP73 MXI1 MYBL2	7.24e-08	877	106	15	20211142
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	HIVEP1 TCF20 TTC28 MUC16 TAB2 TRIM24 PIAS1 CREBBP GSE1 VPS13A CSPP1 RAI1 MYBL2	7.89e-08	638	106	13	31182584
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	TRIM24 PIAS1 TRIM33 GSE1 ZSCAN21 ATF7IP MYBL2	1.19e-07	125	106	7	32891193
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	TET2 TTC28 ATXN7L1 MAST2 MACF1 MBD5 PDZD2	1.55e-07	130	106	7	12421765
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DOCK3 TET2 DMXL2 REPS1 TTC28 CEP85L TTLL5 RANBP9 HUWE1 PIAS1 CREBBP SYNGAP1 TRIM33 EPS15L1 MACF1 HERPUD2 AFF4	3.51e-07	1285	106	17	35914814
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC5B MUC6	5.47e-07	6	106	3	19110483
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ATXN7L1 TNRC6C HUWE1 CREBBP EPS15L1 USF3 ZNF827 MACF1 RIPOR1 SCAF11 PAN3 MAPK6 MBD5 AFF4 RAI1 HTT PDZD2 GULP1	5.67e-07	1489	106	18	28611215
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	HIVEP1 TCF20 RBBP6 DAB2 RFFL ITPRID2 HUWE1 RIF1 EPS15L1 GSE1 RIPOR1 SCAF11 MYBL2	7.07e-07	774	106	13	15302935
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX5 TCF4 HIVEP1 ZBTB33 GATA2 SOX8 FOSL1 USF3 ZFHX4 GLI3 TBXT TP73 MXI1 MYBL2	7.08e-07	908	106	14	19274049
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP36 ZBTB33 TTC28 CNTRL MUC16 HUWE1 TRIM33 RIF1 EPS15L1 NEO1 ATF7IP GLI3 VPS13A	7.38e-07	777	106	13	35844135
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK3 RBBP6 DAB2 ITPRID2 MLLT10 PIAS1 SYNGAP1 USF3 XIRP2 TP73	8.33e-07	430	106	10	35044719
Pubmed	K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression.	HUWE1 CREBBP AFF4	1.52e-06	8	106	3	27934968
Pubmed	Protein phosphatase 1α interacting proteins in the human brain.	MIIP RANBP9 PIAS1 RIF1 ZNF827	1.99e-06	67	106	5	22321011
Pubmed	Functional proteomics mapping of a human signaling pathway.	SOX5 KIF18A HIVEP1 RBBP6 RANBP9 DAB2 HUWE1 PIAS1 CREBBP ATF7IP MACF1	2.01e-06	591	106	11	15231748
Pubmed	Interaction between the scaffold proteins CBP by IQGAP1 provides an interface between gene expression and cytoskeletal activity.	HIVEP1 CNTRL HUWE1 CREBBP GLI3	2.30e-06	69	106	5	32238831
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	HIVEP1 TCF20 TRIM24 PIAS1 PWWP2A RIF1 ZSCAN21 SCAF11 AFF4 RAI1 MYBL2	2.64e-06	608	106	11	36089195
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	SOX5 TET2 HIVEP1 TCF20 TRIM24 CREBBP TRIM33 ZFHX4 ATF7IP	3.80e-06	398	106	9	35016035
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TCF20 TTC28 TNRC6C GSE1 MARK4 MACF1 RIPOR1 MAPKBP1 PDZD2	4.55e-06	407	106	9	12693553
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TTLL5 TAB2 ITPRID2 HUWE1 MAST2	7.24e-06	87	106	5	12465718
Pubmed	Adenovirus E4-ORF3-dependent relocalization of TIF1α and TIF1γ relies on access to the Coiled-Coil motif.	TRIM24 TRIM33	9.20e-06	2	106	2	22123502
Pubmed	Mutations in RAI1 associated with Smith-Magenis syndrome.	TCF20 RAI1	9.20e-06	2	106	2	12652298
Pubmed	TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.	TET2 GATA2	9.20e-06	2	106	2	37794021
Pubmed	CREB-binding proteins (CBP) as a transcriptional coactivator of GATA-2.	GATA2 CREBBP	9.20e-06	2	106	2	18246306
Pubmed	Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.	CREBBP HTT	9.20e-06	2	106	2	16456924
Pubmed	Human T-cell leukemia virus type I tax repression of p73beta is mediated through competition for the C/H1 domain of CBP.	CREBBP TP73	9.20e-06	2	106	2	11279015
Pubmed	Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.	CREBBP HTT	9.20e-06	2	106	2	15994095
Pubmed	Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.	CREBBP HTT	9.20e-06	2	106	2	16766198
Pubmed	A phylogenetic study of SPBP and RAI1: evolutionary conservation of chromatin binding modules.	TCF20 RAI1	9.20e-06	2	106	2	24205348
Pubmed	Phenotypic and molecular convergence of 2q23.1 deletion syndrome with other neurodevelopmental syndromes associated with autism spectrum disorder.	MBD5 RAI1	9.20e-06	2	106	2	25853262
Pubmed	Early alteration of epigenetic-related transcription in Huntington's disease mouse models.	CREBBP HTT	9.20e-06	2	106	2	29967375
Pubmed	Trim24 and Trim33 Play a Role in Epigenetic Silencing of Retroviruses in Embryonic Stem Cells.	TRIM24 TRIM33	9.20e-06	2	106	2	32932986
Pubmed	Cooperative role of RanBP9 and P73 in mitochondria-mediated apoptosis.	RANBP9 TP73	9.20e-06	2	106	2	23348590
Pubmed	Novel interaction between nuclear coactivator CBP and the protein inhibitor of activated Stat1 (PIAS1).	PIAS1 CREBBP	9.20e-06	2	106	2	15957955
Pubmed	Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington's disease model.	PTK2B HTT	9.20e-06	2	106	2	28555636
Pubmed	Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.	CREBBP HTT	9.20e-06	2	106	2	11264541
Pubmed	Protein stability and function of p73 are modulated by a physical interaction with RanBPM in mammalian cultured cells.	RANBP9 TP73	9.20e-06	2	106	2	15558019
Pubmed	A novel murine zinc finger gene mapped within the tw18 deletion region expresses in germ cells and embryonic nervous system.	ZSCAN21 TBXT	9.20e-06	2	106	2	8432396
Pubmed	RGS19 inhibits Ras signaling through Nm23H1/2-mediated phosphorylation of the kinase suppressor of Ras.	RGS19 KSR1	9.20e-06	2	106	2	23416464
Pubmed	A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.	PIAS1 HTT	9.20e-06	2	106	2	34951052
Pubmed	Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.	CREBBP HTT	9.20e-06	2	106	2	22116937
Pubmed	Exosome-transmitted FOSL1 from cancer-associated fibroblasts drives colorectal cancer stemness and chemo-resistance through transcriptionally activating ITGB4.	ITGB4 FOSL1	9.20e-06	2	106	2	37160555
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	USP36 MAN2A1 REPS1 RBBP6 RGS19 RBMS1 ITPRID2 PIAS1 PWWP2A TRIM33 RIF1 SPATS2L CRYBG1 MACF1 SCAF11 AFF4	1.22e-05	1497	106	16	31527615
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	USP36 DOCK3 HIVEP1 RBBP6 MAST2 GSE1 ZFHX4 MACF1	1.55e-05	361	106	8	26167880
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	TCF4 ZBTB33 TCF20 RIF1 GLI3	2.17e-05	109	106	5	33554859
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	DMXL2 HIVEP1 REPS1 TAB2 MAST2 NEO1 GSE1 XIRP2 MACF1	2.23e-05	497	106	9	23414517
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	ITPRID2 CREBBP FOSL1 EPS15L1 TP73	2.27e-05	110	106	5	37219487
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	RANBP9 PIAS1 TRIM33 ZFHX4 GLI3 MACF1 TP73	2.63e-05	282	106	7	23667531
Pubmed	The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.	TRIM24 TRIM33	2.76e-05	3	106	2	10439047
Pubmed	Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.	CREBBP HTT	2.76e-05	3	106	2	11607033
Pubmed	Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains.	TRIM24 TRIM33	2.76e-05	3	106	2	36098557
Pubmed	CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis.	TET2 GATA2	2.76e-05	3	106	2	23521373
Pubmed	TRIM33 protects osteoblasts from oxidative stress-induced apoptosis in osteoporosis by inhibiting FOXO3a ubiquitylation and degradation.	CREBBP TRIM33	2.76e-05	3	106	2	34101965
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	2.76e-05	3	106	2	26770020
Pubmed	The ePHD protein SPBP interacts with TopBP1 and together they co-operate to stimulate Ets1-mediated transcription.	TCF20 RAI1	2.76e-05	3	106	2	17913746
Pubmed	Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations.	ATF7IP HTT	2.76e-05	3	106	2	30452683
Pubmed	Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation.	CREBBP HTT	2.76e-05	3	106	2	15225551
Pubmed	TET2 promotes IL-1β expression in J774.1 cell through TLR4/MAPK signaling pathway with demethylation of TAB2 promoter.	TET2 TAB2	2.76e-05	3	106	2	32823238
Pubmed	Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes.	ITGB4 FOSL1	2.76e-05	3	106	2	19923172
Pubmed	Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia.	GATA2 CREBBP	2.76e-05	3	106	2	18250304
Pubmed	PIASy interacts with p73alpha and regulates cell cycle in HEK293 cells.	PIAS1 TP73	2.76e-05	3	106	2	20471636
Pubmed	Expression of the beta 4 integrin subunit induces monocytic differentiation of 32D/v-Abl cells.	ITGB4 TP73	2.76e-05	3	106	2	12070014
Pubmed	PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease.	PIAS1 HTT	2.76e-05	3	106	2	33468657
Pubmed	Mediator modulates Gli3-dependent Sonic hedgehog signaling.	CREBBP GLI3	2.76e-05	3	106	2	17000779
Pubmed	Sonic Hedgehog-induced activation of the Gli1 promoter is mediated by GLI3.	CREBBP GLI3	2.76e-05	3	106	2	10075717
Pubmed	Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression.	TRIM24 TRIM33	2.76e-05	3	106	2	12096914
Pubmed	DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.	MUC16 MUC5B	2.76e-05	3	106	2	27230679
Pubmed	CBP/p300 are bimodal regulators of Wnt signaling.	TCF4 CREBBP	2.76e-05	3	106	2	17410209
Pubmed	Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design.	TRIM24 TRIM33	2.76e-05	3	106	2	36430693
Pubmed	PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.	PIAS1 TRIM33	2.76e-05	3	106	2	32770107
Pubmed	Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.	CREBBP MYBL2	2.76e-05	3	106	2	11423988
Pubmed	DNA hypermethylation is associated with invasive phenotype of malignant melanoma.	TET2 NAV2	2.76e-05	3	106	2	31602702
Pubmed	Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival.	CREBBP HTT	2.76e-05	3	106	2	16207717
Pubmed	The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis.	CREBBP TP73	2.76e-05	3	106	2	10648616
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	KIF18A TTC28 TTLL5 RANBP9 HUWE1 CREBBP PWWP2A EPS15L1 CSPP1 RAI1	2.90e-05	645	106	10	25281560
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DMXL2 TCF20 RANBP9 HUWE1 SYNGAP1 EPS15L1 ATF7IP MACF1 FRMPD3 TNS1 AFF4 RAI1	3.84e-05	963	106	12	28671696
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	ITPRID2 SYNGAP1 PWWP2A RIPOR1	4.23e-05	63	106	4	11572484
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ZBTB33 REPS1 TCF20 TTC28 RBBP6 HUWE1 CREBBP EPS15L1 HTT	4.82e-05	549	106	9	38280479
Pubmed	Nuclear protein CBP is a coactivator for the transcription factor CREB.	CREBBP GLI3	5.50e-05	4	106	2	7913207
Pubmed	KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer.	TRIM24 TRIM33	5.50e-05	4	106	2	34392614
Pubmed	Inactivation of the mouse Huntington's disease gene homolog Hdh.	TBXT HTT	5.50e-05	4	106	2	7618107
Pubmed	Charge movement and transcription regulation of L-type calcium channel alpha(1S) in skeletal muscle cells.	SOX5 GATA2	5.50e-05	4	106	2	11956331
Pubmed	The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis.	TCF4 MLLT10	5.50e-05	4	106	2	21103407
Pubmed	TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage.	TRIM24 TRIM33	5.50e-05	4	106	2	24820418
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC6	5.50e-05	4	106	2	23807779
Pubmed	Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer.	TCF4 CREBBP	5.50e-05	4	106	2	24532795
Interaction	ERG interactions	TET2 HIVEP1 TCF20 HUWE1 MLLT10 TRIM24 PIAS1 CREBBP TRIM33 GSE1 ZFHX4 ATF7IP	1.77e-09	223	104	12	int:ERG
Interaction	FEV interactions	SOX5 HIVEP1 TCF20 MLLT10 TRIM24 PIAS1 CREBBP GSE1 ZFHX4 ZSCAN21 MYBL2	8.14e-09	203	104	11	int:FEV
Interaction	HNF1B interactions	SOX5 TET2 HIVEP1 MLLT10 TRIM24 PIAS1 CREBBP GSE1 ZFHX4 ATF7IP	5.30e-08	190	104	10	int:HNF1B
Interaction	SP7 interactions	SOX5 TET2 HIVEP1 TCF20 RBBP6 TRIM24 CREBBP TRIM33 GSE1 ZFHX4 ZSCAN21 MYBL2	5.61e-08	304	104	12	int:SP7
Interaction	AR interactions	TET2 TCF4 HIVEP1 ZBTB33 TCF20 RANBP9 TAB2 ITPRID2 HUWE1 TRIM24 PIAS1 CREBBP TRIM33 SPATS2L GSE1 ZSCAN21 GLI3 TNS1 AFF4 RAI1	1.44e-07	992	104	20	int:AR
Interaction	TBXT interactions	HIVEP1 TCF20 TRIM24 CREBBP GSE1 ZFHX4 ZSCAN21 TBXT	1.54e-07	116	104	8	int:TBXT
Interaction	YWHAH interactions	MIIP TET2 HIVEP1 TCF20 TTC28 CEP85L COBLL1 CNTRL TAB2 ITPRID2 HUWE1 MAST2 CREBBP SYNGAP1 KSR1 MARK4 NAV2 MACF1 PAN3 CSPP1 HTT	1.71e-07	1102	104	21	int:YWHAH
Interaction	SOX7 interactions	SOX5 TET2 TCF20 TRIM24 CREBBP TRIM33 ZFHX4	2.20e-07	82	104	7	int:SOX7
Interaction	CREBBP interactions	HIVEP1 CNTRL GATA2 HUWE1 TRIM24 PIAS1 CREBBP FOSL1 TRIM33 ATF7IP GLI3 TBXT HTT TP73 MYBL2	4.35e-07	599	104	15	int:CREBBP
Interaction	HMG20A interactions	SOX5 TCF4 TCF20 GATA2 RANBP9 CREBBP GSE1 TBXT RAI1 HTT	5.43e-07	244	104	10	int:HMG20A
Interaction	TLE3 interactions	TET2 TCF4 HIVEP1 TCF20 RBBP6 GATA2 MLLT10 PIAS1 CREBBP GSE1 TBXT MYBL2	5.52e-07	376	104	12	int:TLE3
Interaction	ASF1A interactions	HIVEP1 TCF20 TRIM24 TRIM33 RIF1 GSE1 PAN3 RAI1 TP73 MYBL2	6.53e-07	249	104	10	int:ASF1A
Interaction	TERF2IP interactions	HIVEP1 ARPP21 TCF20 RBBP6 TRIM24 PIAS1 CREBBP TRIM33 RIF1 ATF7IP SCAF11 AFF4 RAI1 MYBL2	9.40e-07	552	104	14	int:TERF2IP
Interaction	YWHAG interactions	MIIP TET2 HIVEP1 ZBTB33 TTC28 CEP85L COBLL1 TAB2 ITPRID2 HUWE1 MAST2 PIAS1 SYNGAP1 KSR1 MARK4 NAV2 MACF1 SCAF11 PAN3 CSPP1 HTT	1.31e-06	1248	104	21	int:YWHAG
Interaction	KDM1A interactions	TET2 TCF4 HIVEP1 ZBTB33 TCF20 TTC28 GATA2 RANBP9 HUWE1 SOX8 TRIM24 GSE1 ZFHX4 ATF7IP TBXT HTT TP73 MYBL2	1.41e-06	941	104	18	int:KDM1A
Interaction	NFIC interactions	SOX5 TET2 HIVEP1 GATA2 TRIM24 CREBBP GSE1 TBXT SCAF11	1.43e-06	210	104	9	int:NFIC
Interaction	RCOR1 interactions	SOX5 TCF4 HIVEP1 ZBTB33 TTC28 GATA2 RANBP9 HUWE1 SOX8 GSE1 ZFHX4 ZNF827 TBXT	1.58e-06	494	104	13	int:RCOR1
Interaction	GLUL interactions	DMXL2 RBBP6 RANBP9 HUWE1 PIAS1 SYNGAP1 MAPK6 HTT	1.79e-06	160	104	8	int:GLUL
Interaction	NCOR1 interactions	SOX5 KIF18A ZBTB33 GATA2 TAB2 PIAS1 CREBBP TRIM33 TBXT HTT MYBL2	2.78e-06	363	104	11	int:NCOR1
Interaction	SOX2 interactions	SOX5 TET2 HIVEP1 TCF20 RBMS1 RANBP9 ITPRID2 EYA1 SOX8 MAST2 TRIM24 PIAS1 ITGB4 TRIM33 SPATS2L GSE1 ZFHX4 GLI3 NAV2 MACF1 TP73 MYBL2	2.80e-06	1422	104	22	int:SOX2
Interaction	EGR2 interactions	SOX5 TET2 HIVEP1 SOX8 TRIM24 CREBBP TRIM33 ZFHX4	2.94e-06	171	104	8	int:EGR2
Interaction	YWHAZ interactions	MIIP TET2 DMXL2 HIVEP1 ZBTB33 TTC28 CEP85L COBLL1 TAB2 ITPRID2 HUWE1 MAST2 PIAS1 SYNGAP1 KSR1 MARK4 NAV2 MACF1 SCAF11 TNS1 HTT	3.15e-06	1319	104	21	int:YWHAZ
Interaction	HDAC1 interactions	USP36 TET2 HIVEP1 ZBTB33 TCF20 TTC28 RANBP9 TAB2 SOX8 CREBBP FOSL1 PWWP2A GSE1 ZFHX4 ZNF827 GLI3 RAI1 TP73 MXI1	3.47e-06	1108	104	19	int:HDAC1
Interaction	EYA4 interactions	TET2 TCF4 GATA2 TNRC6C EYA1 CREBBP SPATS2L GSE1 FAM222B	4.72e-06	243	104	9	int:EYA4
Interaction	LHX3 interactions	SOX5 HIVEP1 TCF20 TRIM24 CREBBP GSE1 ZFHX4 MYBL2	5.27e-06	185	104	8	int:LHX3
Interaction	SGIP1 interactions	REPS1 DAB2 SYNGAP1 EPS15L1 CRYBG1	5.85e-06	50	104	5	int:SGIP1
Interaction	CRX interactions	SOX5 TET2 TCF20 TRIM24 PIAS1 CREBBP TRIM33 ZFHX4 RAI1	6.75e-06	254	104	9	int:CRX
Interaction	FOXI1 interactions	MLLT10 TRIM24 CREBBP TRIM33 GSE1 ZFHX4	8.13e-06	92	104	6	int:FOXI1
Interaction	SUMO2 interactions	USP36 ZBTB33 DAB2 HUWE1 MAST2 TRIM24 PIAS1 TRIM33 RIF1 ATF7IP SCAF11 MAPK6 HTT	1.11e-05	591	104	13	int:SUMO2
Interaction	SFN interactions	MIIP TET2 ZBTB33 COBLL1 TAB2 ITPRID2 MAST2 PIAS1 KSR1 NAV2 MACF1 PAN3 MAPK6 HTT	1.27e-05	692	104	14	int:SFN
Interaction	TOP3B interactions	DOCK3 REPS1 RBMS1 GATA2 ANKLE1 TNRC6C HUWE1 MLLT10 MAST2 ITGB4 EPS15L1 ZNF827 MARK4 NAV2 RIPOR1 MAPKBP1 MBD5 BCL2L13 RAI1 HTT MYBL2	1.67e-05	1470	104	21	int:TOP3B
Interaction	NME7 interactions	TCF4 CNTRL TNRC6C HUWE1 FOSL1 SCAF11 CSPP1	1.94e-05	160	104	7	int:NME7
Interaction	NEUROD1 interactions	TCF4 EYA1 CREBBP HTT	2.15e-05	32	104	4	int:NEUROD1
Interaction	TBR1 interactions	SOX5 TET2 HIVEP1 GSE1 ZFHX4 TBXT	2.64e-05	113	104	6	int:TBR1
Interaction	GCM1 interactions	TET2 HIVEP1 CREBBP GSE1 ZSCAN21	2.68e-05	68	104	5	int:GCM1
Interaction	NLK interactions	TAB2 CREBBP FAM222B HTT MYBL2	3.08e-05	70	104	5	int:NLK
Interaction	PTOV1 interactions	ACRBP HUWE1 CREBBP MAPK6 PDZD2	3.08e-05	70	104	5	int:PTOV1
Interaction	FOSL1 interactions	CNTRL TAB2 TRIM24 CREBBP FOSL1	3.08e-05	70	104	5	int:FOSL1
Interaction	UBE2I interactions	USP36 SOX5 TCF4 RBBP6 RBMS1 RANBP9 TAB2 TRIM24 PIAS1 CREBBP TRIM33 ATF7IP TP73	3.20e-05	654	104	13	int:UBE2I
Interaction	MTA3 interactions	SOX5 TCF20 ACRBP PWWP2A GSE1 ZNF827 MYBL2	3.21e-05	173	104	7	int:MTA3
Interaction	PRKCD interactions	RANBP9 DAB2 ITGB4 CREBBP PTK2B MACF1 HTT TP73	3.27e-05	238	104	8	int:PRKCD
Interaction	CHD3 interactions	USP36 SOX5 PIAS1 CREBBP PWWP2A RIF1 GSE1 ZFHX4 ZNF827 SCAF11 RAI1 HTT TP73 MYBL2	3.43e-05	757	104	14	int:CHD3
Interaction	TLX1 interactions	HIVEP1 TCF20 PIAS1 CREBBP GSE1 ZFHX4 ZSCAN21	3.45e-05	175	104	7	int:TLX1
Interaction	AMPH interactions	REPS1 SYNGAP1 MAPK6 HTT TP73	3.53e-05	72	104	5	int:AMPH
Interaction	HLF interactions	TET2 CREBBP PER3	3.68e-05	13	104	3	int:HLF
Interaction	PRKCG interactions	RANBP9 DAB2 HUWE1 SYNGAP1 MARK4 HTT	3.88e-05	121	104	6	int:PRKCG
Interaction	TRIM24 interactions	SOX5 TCF4 GATA2 TNRC6C TRIM24 CREBBP FOSL1 TRIM33 TBXT AFF4	4.04e-05	398	104	10	int:TRIM24
Interaction	CBFA2T3 interactions	TCF4 ZBTB33 RANBP9 TRIM33 GSE1	5.20e-05	78	104	5	int:CBFA2T3
Interaction	SMC5 interactions	USP36 HIVEP1 ZBTB33 TCF20 RBBP6 RBMS1 TRIM24 TRIM33 RIF1 EPS15L1 ZSCAN21 ATF7IP SCAF11 AFF4 RAI1 MYBL2	5.21e-05	1000	104	16	int:SMC5
Interaction	YWHAB interactions	MIIP TET2 HIVEP1 TTC28 CEP85L COBLL1 RANBP9 ITPRID2 MAST2 ITGB4 TRIM33 KSR1 MARK4 NAV2 MACF1 HTT	6.15e-05	1014	104	16	int:YWHAB
Interaction	MYOD1 interactions	TCF4 HIVEP1 HUWE1 TRIM24 CREBBP TRIM33 GSE1	6.64e-05	194	104	7	int:MYOD1
Interaction	YWHAE interactions	MIIP TET2 HIVEP1 ZBTB33 TTC28 CEP85L COBLL1 TAB2 ITPRID2 HUWE1 MAST2 SYNGAP1 KSR1 MARK4 NAV2 MACF1 SCAF11 HTT	7.08e-05	1256	104	18	int:YWHAE
Interaction	GATA2 interactions	HIVEP1 GATA2 TRIM24 PIAS1 CREBBP GSE1 ZFHX4	7.79e-05	199	104	7	int:GATA2
Interaction	TBL1X interactions	SOX5 GATA2 TAB2 HUWE1 TRIM33 TBXT	8.09e-05	138	104	6	int:TBL1X
Interaction	ZMYM2 interactions	TRIM24 PIAS1 CREBBP TRIM33 GSE1 ZSCAN21 ATF7IP MYBL2	8.15e-05	271	104	8	int:ZMYM2
Interaction	XRCC6 interactions	USP36 TCF4 ZBTB33 TCF20 RBBP6 HUWE1 TRIM24 PIAS1 CREBBP RIF1 GSE1 SCAF11 MBD5 AFF4 HTT	8.18e-05	928	104	15	int:XRCC6
Interaction	CLTA interactions	TET2 REPS1 DAB2 TAB2 TNRC6C PIAS1 EPS15L1 HTT MYBL2	8.55e-05	351	104	9	int:CLTA
Interaction	PML interactions	TET2 KIF18A ZBTB33 REPS1 GATA2 TRIM24 PIAS1 CREBBP TRIM33 EPS15L1 SPATS2L ZSCAN21 ATF7IP HTT TP73	8.68e-05	933	104	15	int:PML
Interaction	DAXX interactions	TCF4 MLLT10 PIAS1 CREBBP ATF7IP MACF1 AFF4 RAI1 TP73	8.93e-05	353	104	9	int:DAXX
Interaction	HNF4A interactions	HIVEP1 TRIM24 PIAS1 CREBBP TRIM33 GSE1 ATF7IP MYBL2	9.02e-05	275	104	8	int:HNF4A
Interaction	NFIB interactions	SOX5 HIVEP1 GATA2 CREBBP GSE1 TBXT	9.48e-05	142	104	6	int:NFIB
Interaction	CNOT3 interactions	RBMS1 TNRC6C HUWE1 TRIM24 CREBBP GLI3 HTT	9.97e-05	207	104	7	int:CNOT3
Interaction	TNRC6A interactions	RBMS1 CNTRL TNRC6C TRIM24 ITGB4 GLI3 PAN3 AFF4	1.02e-04	280	104	8	int:TNRC6A
Interaction	DUXB interactions	TRIM24 TRIM33 ZFHX4	1.03e-04	18	104	3	int:DUXB
Interaction	H2BC9 interactions	HIVEP1 ADGRG4 PWWP2A USF3 ZFHX4 XIRP2 MAPK6 MBD5 AFF4 RAI1	1.04e-04	446	104	10	int:H2BC9
Interaction	FBXO38 interactions	KIF18A HIVEP1 ATXN7L1 TRIM24 CREBBP MYBL2	1.06e-04	145	104	6	int:FBXO38
Interaction	MAPK1 interactions	TCF20 RGS19 GATA2 RFFL HUWE1 CREBBP SYNGAP1 KSR1 MAPK6 RAI1 HTT	1.14e-04	543	104	11	int:MAPK1
Interaction	TAL1 interactions	TCF4 HIVEP1 GATA2 CREBBP TRIM33	1.20e-04	93	104	5	int:TAL1
Interaction	NEUROG1 interactions	TCF4 EYA1 CREBBP	1.22e-04	19	104	3	int:NEUROG1
Interaction	ATXN1L interactions	SOX5 HIVEP1 GATA2 DAB2 TBXT SCAF11	1.28e-04	150	104	6	int:ATXN1L
Interaction	NR3C1 interactions	DOCK3 HIVEP1 TCF20 TTC28 RANBP9 MUC16 TAB2 TRIM24 PIAS1 CREBBP GSE1 VPS13A CSPP1 RAI1 MYBL2	1.40e-04	974	104	15	int:NR3C1
Interaction	NUCKS1 interactions	REPS1 TCF20 HUWE1 TRIM24 RIF1 RAI1 HTT	1.46e-04	220	104	7	int:NUCKS1
Interaction	GSE1 interactions	SOX5 TCF4 GATA2 RANBP9 GSE1 TBXT	1.48e-04	154	104	6	int:GSE1
Interaction	SIN3A interactions	TET2 TCF20 TAB2 CREBBP PWWP2A GSE1 HTT MXI1 MYBL2	1.56e-04	380	104	9	int:SIN3A
Interaction	JUN interactions	TCF4 TCF20 GATA2 SOX8 PIAS1 CREBBP FOSL1 TRIM33 MACF1 TP73	1.60e-04	470	104	10	int:JUN
Interaction	NFIX interactions	SOX5 HIVEP1 TRIM24 GSE1 ZFHX4 ZSCAN21 MYBL2	1.77e-04	227	104	7	int:NFIX
Interaction	SLX4 interactions	USP36 KIF18A TCF20 ATXN7L1 TRIM24 PIAS1 CREBBP TRIM33 ATF7IP AFF4 MYBL2	1.80e-04	572	104	11	int:SLX4
Interaction	SOX5 interactions	SOX5 TCF20 TRIM24 GSE1 ZFHX4 ATF7IP	1.95e-04	162	104	6	int:SOX5
Interaction	CDC20 interactions	KIF18A HUWE1 CREBBP TRIM33 TP73 MXI1 MYBL2	2.13e-04	234	104	7	int:CDC20
Interaction	POU5F1 interactions	SOX5 TCF4 TCF20 MUC16 HUWE1 MLLT10 SOX8 TRIM24 TRIM33 RIF1 SCAF11	2.15e-04	584	104	11	int:POU5F1
Interaction	H3C1 interactions	USP36 COBLL1 TRIM24 PIAS1 CREBBP TRIM33 RIF1 SPATS2L ZSCAN21 XIRP2 NAV2 MBD5 AFF4 PDZD2	2.17e-04	901	104	14	int:H3C1
Interaction	LRRC7 interactions	SYNGAP1 EPS15L1 MACF1 HTT	2.29e-04	58	104	4	int:LRRC7
Interaction	H3C3 interactions	HIVEP1 TCF20 TRIM24 PIAS1 PWWP2A RIF1 ZSCAN21 SCAF11 AFF4 RAI1	2.42e-04	495	104	10	int:H3C3
Interaction	H2BC21 interactions	TCF20 ATXN7L1 HUWE1 MLLT10 TRIM24 CREBBP PWWP2A RIF1 USF3 CRYBG1 SCAF11 RAI1	2.48e-04	696	104	12	int:H2BC21
Interaction	SMG7 interactions	HIVEP1 TCF20 RBMS1 TNRC6C MLLT10 TRIM24 CREBBP GSE1	2.49e-04	319	104	8	int:SMG7
Interaction	PRR20A interactions	SOX5 HIVEP1 GATA2 ATF7IP FAM222B	2.54e-04	109	104	5	int:PRR20A
Interaction	PCNT interactions	DMXL2 CEP85L CNTRL HUWE1 SYNGAP1 MACF1 CSPP1	2.54e-04	241	104	7	int:PCNT
Interaction	APEX1 interactions	MIIP USP36 HIVEP1 TCF20 CEP85L DAB2 C11orf24 TRIM24 ITGB4 RIF1 EPS15L1 GSE1 ZSCAN21 SCAF11 AFF4 RAI1 TP73	2.63e-04	1271	104	17	int:APEX1
Interaction	SMAD1 interactions	SOX5 TET2 TCF20 PIAS1 CREBBP GLI3 MXI1	2.68e-04	243	104	7	int:SMAD1
Interaction	PAX8 interactions	TET2 HIVEP1 CREBBP GSE1 ZFHX4	2.76e-04	111	104	5	int:PAX8
Interaction	PIAS4 interactions	TCF4 TRIM24 PIAS1 RIF1 ATF7IP HTT	2.78e-04	173	104	6	int:PIAS4
Interaction	MZT1 interactions	REPS1 RBBP6 RGS19 SCAF11	2.79e-04	61	104	4	int:MZT1
Interaction	FOXM1 interactions	KIF18A TCF4 ZBTB33 CREBBP MYBL2	3.00e-04	113	104	5	int:FOXM1
Interaction	KLF8 interactions	SOX5 HIVEP1 TRIM24 CREBBP TRIM33 ZSCAN21 ATF7IP MYBL2	3.07e-04	329	104	8	int:KLF8
Interaction	DBN1 interactions	SOX5 RANBP9 DAB2 TAB2 ITPRID2 PIAS1 SYNGAP1 MAPK6 HTT	3.10e-04	417	104	9	int:DBN1
Interaction	HMGA1 interactions	TCF20 RANBP9 PIAS1 CREBBP PWWP2A RIF1 SCAF11 RAI1 HTT	3.21e-04	419	104	9	int:HMGA1
Interaction	SATB1 interactions	SOX5 GATA2 PIAS1 TBXT HTT	3.38e-04	116	104	5	int:SATB1
Interaction	SAP130 interactions	SOX5 TET2 GATA2 PWWP2A TBXT MYBL2	3.54e-04	181	104	6	int:SAP130
Interaction	USP7 interactions	USP36 DOCK3 TET2 TCF20 COBLL1 GATA2 RANBP9 RFFL HUWE1 MAST2 CREBBP TRIM33 GLI3 MARK4 NAV2 MACF1 AFF4	3.83e-04	1313	104	17	int:USP7
Interaction	ETS1 interactions	HIVEP1 RBBP6 HUWE1 TRIM24 CREBBP	4.11e-04	121	104	5	int:ETS1
GeneFamily	CD molecules\|Mucins	MUC16 MUC5B MUC12 MUC17 MUC6	1.46e-08	21	70	5	648
GeneFamily	Tubulin tyrosine ligase family	TTLL5 TTLL8	1.30e-03	14	70	2	779
Coexpression	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	COBLL1 RANBP9 PIAS1 CREBBP USF3 ATF7IP MACF1 MAPK6 AFF4	1.24e-06	265	105	9	M1684
Coexpression	DURCHDEWALD_SKIN_CARCINOGENESIS_DN	COBLL1 RANBP9 PIAS1 CREBBP USF3 ATF7IP MACF1 MAPK6 AFF4	1.54e-06	272	105	9	MM1027
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DMXL2 HIVEP1 MAN2A1 TTC28 RBMS1 TAB2 MAST2 TRIM24 CREBBP TRIM33 RIF1 GSE1 VPS13A MACF1 MAPK6	1.64e-06	856	105	15	M4500
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	TET2 TCF4 RBBP6 RBMS1 TTLL5 DAB2 RFFL SOX8 SSC5D NEO1 SPATS2L PER3 NAV2 HERPUD2 TNS1 HTT MXI1	1.77e-06	1102	105	17	M2369
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	TET2 RBMS1 SPATS2L MACF1 PAN3 MBD5 CSPP1 GULP1	2.28e-06	212	105	8	M39221
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	TET2 TCF4 RBBP6 RBMS1 TTLL5 DAB2 RFFL SOX8 SSC5D NEO1 SPATS2L PER3 NAV2 HERPUD2 TNS1 HTT MXI1	2.31e-06	1124	105	17	MM1070
Coexpression	GABRIELY_MIR21_TARGETS	COBLL1 CNTRL TRIM33 PER3 VPS13A CRYBG1 SCAF11 PAN3 HERPUD2	2.53e-06	289	105	9	M2196
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	RBBP6 CEP85L RGS19 RBMS1 CNTRL GATA2 RANBP9 TAB2 TNRC6C HUWE1 CREBBP TRIM33 PTK2B RIF1 ATF7IP CRYBG1 MACF1 SCAF11 HERPUD2	6.74e-06	1492	105	19	M40023
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	TET2 MAST2 CREBBP TRIM33 RIF1 ATF7IP MACF1	8.28e-06	180	105	7	M8239
Coexpression	GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN	TET2 HIVEP1 RBMS1 KSR1 MAPKBP1 MXI1 MYBL2	1.59e-05	199	105	7	M9744
Coexpression	GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP	TCF4 TNRC6C HUWE1 TRIM24 RIPOR1 HERPUD2 ALPK2	1.64e-05	200	105	7	M6035
Coexpression	KORKOLA_EMBRYONAL_CARCINOMA_DN	SOX5 ACRBP ATF7IP	1.74e-05	13	105	3	M12977
Coexpression	KORKOLA_SEMINOMA_DN	SOX5 ACRBP ATF7IP	1.74e-05	13	105	3	M632
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	TCF4 TTC28 RBMS1 PIAS1 MACF1 PAN3	1.92e-05	137	105	6	M39241
Coexpression	MURARO_PANCREAS_BETA_CELL	DMXL2 ZBTB33 COBLL1 TAB2 HUWE1 NEO1 USF3 PER3 GSE1 NAV2 TNS1 AFF4 MXI1 PDZD2	2.51e-05	946	105	14	M39169
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	USP36 HIVEP1 TCF20 CREBBP TRIM33 PER3 GSE1 ATF7IP NAV2 RIPOR1 AFF4 MXI1 PDZD2	2.53e-05	822	105	13	M6782
Coexpression	AIZARANI_LIVER_C20_LSECS_3	TCF4 RBBP6 RBMS1 DAB2 FOSL1 MACF1 RIPOR1 AFF4	2.54e-05	295	105	8	M39121
Coexpression	CUI_TCF21_TARGETS_2_DN	HIVEP1 RBBP6 CEP85L ATXN7L1 RBMS1 RANBP9 ITPRID2 CREBBP VPS13A MACF1 RIPOR1 MBD5 GULP1	3.75e-05	854	105	13	M1533
Coexpression	AMIT_DELAYED_EARLY_GENES	RBMS1 PIAS1 FOSL1	4.88e-05	18	105	3	M10550
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	MAN2A1 TCF20 TTC28 CEP85L RBMS1 TAB2 EYA1 SOX8 CREBBP SPATS2L GSE1 ATF7IP NAV2 MAPK6	5.06e-05	1009	105	14	M157
Coexpression	CUI_TCF21_TARGETS_2_DN	HIVEP1 RBBP6 CEP85L ATXN7L1 RBMS1 RANBP9 ITPRID2 CREBBP VPS13A MACF1 RIPOR1 MBD5 GULP1	5.58e-05	888	105	13	MM1018
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	TET2 CNTRL TNRC6C EPS15L1 NAV2 MACF1	5.65e-05	166	105	6	M6826
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	TTC28 SPATS2L VPS13A MBD5 ALPK2 GULP1	7.82e-05	176	105	6	M39223
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	TCF4 TAB2 RFFL ITPRID2 PIAS1 KSR1 NEO1 PER3 ATF7IP TNS1 AFF4 MXI1	9.49e-05	807	105	12	M16651
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN	TCF4 DMXL2 TCF20 DAB2 HUWE1 ATF7IP AFF4	1.07e-04	269	105	7	M41203
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	HIVEP1 ATXN7L1 RIF1 USF3 MACF1 AFF4	1.16e-04	189	105	6	M3112
Coexpression	GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP	TCF4 RBBP6 COBLL1 ATF7IP VPS13A MXI1	1.30e-04	193	105	6	M4961
Coexpression	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN	TCF4 ARPP21 RANBP9 CREBBP RIPOR1 MYBL2	1.30e-04	193	105	6	M6903
Coexpression	GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP	TRIM24 ZFHX4 ATF7IP VPS13A MACF1 MYBL2	1.45e-04	197	105	6	M8983
Coexpression	GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN	TCF4 HIVEP1 REPS1 MLLT10 MAPKBP1 MUC6	1.49e-04	198	105	6	M5171
Coexpression	BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP	TET2 HIVEP1 RBBP6 CEP85L FOSL1 PER3 ALPK3 NAV2 MUC6	1.50e-04	486	105	9	M34018
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	TCF20 C11orf24 PIAS1 ITGB4 FAM222B AFF4	1.53e-04	199	105	6	M7254
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN	MAN2A1 RANBP9 RFFL PIAS1 MAPK6 ALPK2	1.57e-04	200	105	6	M3973
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE	RBMS1 DAB2 HUWE1 NDST3 VPS13A PAN3	2.10e-04	211	105	6	MM17081
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	TTC28 VPS13A MBD5 CSPP1 TNS1 PDZD2	2.70e-04	221	105	6	M39222
Coexpression	THUM_SYSTOLIC_HEART_FAILURE_DN	RBBP6 MLLT10 RIF1 PER3 SCAF11 PDZD2	3.11e-04	227	105	6	M18441
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	DMXL2 REPS1 TCF20 TTC28 RBBP6 TTLL5 C11orf24 TAB2 RFFL HUWE1 MAST2 SYNGAP1 USF3 VPS13A MACF1 SCAF11 MBD5 AFF4 GULP1	8.25e-09	780	105	19	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	REPS1 TTC28 C11orf24 RFFL USF3 MACF1 SCAF11 MBD5 AFF4	1.43e-05	291	105	9	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	ARPP21 REPS1 CEP85L GATA2 RANBP9 C11orf24 EYA1 TRIM24 PTK2B SSC5D RIF1 ZFHX4 GLI3 MACF1 CSPP1 MUC6	2.76e-05	989	105	16	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	KIF18A DMXL2 TCF20 RBBP6 TAB2 RFFL HUWE1 MAST2 SYNGAP1 RIF1 GLI3 VPS13A AFF4 MXI1	5.97e-05	831	105	14	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	DOCK3 SOX5 KIF18A ZBTB33 RBBP6 CEP85L CNTRL ANKLE1 SOX8 TRIM24 RIF1 GLI3 VPS13A MACF1 SCAF11 MAPK6 MBD5 CSPP1 MYBL2	8.89e-05	1459	105	19	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	HIVEP1 ZBTB33 REPS1 RANBP9 C11orf24 TRIM24 TRIM33 EPS15L1 MACF1 RIPOR1 CSPP1	1.10e-04	564	105	11	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	KIF18A TCF4 REPS1 CEP85L RFFL TRIM24 RIF1 GLI3 SCAF11 PAN3	1.11e-04	469	105	10	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	SOX5 KIF18A ZBTB33 RBBP6 CEP85L CNTRL ANKLE1 TRIM24 RIF1 GLI3 VPS13A MACF1 SCAF11 MAPK6 MBD5 CSPP1 MYBL2	1.40e-04	1257	105	17	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000	TCF4 HIVEP1 TTC28 RBBP6 GATA2 RANBP9 TNRC6C NEO1 ZFHX4 ZNF827 GLI3 MAPKBP1 GULP1	1.43e-04	791	105	13	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500	ARPP21 CEP85L GATA2 EYA1 PTK2B SSC5D RIF1 ZFHX4 GLI3 MUC6	1.64e-04	492	105	10	Facebase_RNAseq_e10.5_Maxillary Arch_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	SOX5 DMXL2 HUWE1 TRIM24 CREBBP PWWP2A RIF1 ZFHX4 FAM222B NAV2 SCAF11 CSPP1 GULP1	1.68e-04	804	105	13	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000	TNRC6C EYA1 HUWE1 ZFHX4 ZNF827 TBXT PDZD2	2.07e-04	243	105	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	ZBTB33 REPS1 RANBP9 TRIM24 TRIM33 RIF1 EPS15L1 GLI3 MACF1 HERPUD2 CSPP1	2.83e-04	629	105	11	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3	ARPP21 TRIM24 GSE1 NAV2 RIPOR1 PAN3 TNS1 RAI1	3.06e-04	343	105	8	GSM399400_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	REPS1 TTC28 GATA2 C11orf24 RFFL SOX8 USF3 ZFHX4 MACF1 SCAF11 MBD5 TNS1 MUC6 AFF4	3.50e-04	985	105	14	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	SOX5 TRIM24 SYNGAP1 NEO1 ZFHX4 NAV2	3.77e-04	191	105	6	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#1_top-relative-expression-ranked_1000	TCF4 TTC28 RANBP9 ZFHX4 ZNF827 GLI3	4.21e-04	195	105	6	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k1
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	SOX5 TET2 KIF18A ZBTB33 CEP85L RGS19 CNTRL TAB2 EYA1 TRIM24 TRIM33 KSR1 RIF1 GLI3 VPS13A MBD5	4.22e-04	1252	105	16	facebase_RNAseq_e10.5_MaxArch_2500_K3
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 MAN2A1 TTC28 RBMS1 TRIM24 SCAF11 MBD5 AFF4	2.09e-08	193	106	8	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SOX5 TCF4 TTC28 NEO1 ZFHX4 GLI3 MACF1 MBD5	2.26e-08	195	106	8	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 MAN2A1 TTC28 TRIM24 SCAF11 MBD5 AFF4	3.94e-07	192	106	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SOX5 TCF4 TTC28 GSE1 ZFHX4 GLI3 MACF1	4.23e-07	194	106	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 HUWE1 RIF1 VPS13A NAV2 MACF1 AFF4	4.37e-07	195	106	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 HUWE1 RIF1 VPS13A NAV2 MACF1 SCAF11	4.37e-07	195	106	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	COBLL1 CREBBP USF3 ATF7IP MACF1 MXI1	3.21e-06	169	106	6	c3a6179a64589a370108fea809b157839347759c
ToppCell	CV-Mild-6\|Mild / Virus stimulation, Condition and Cluster	USP36 RGS19 CREBBP FRMPD3 MBD5 ALPK2	3.93e-06	175	106	6	c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B KSR1 MACF1 AFF4 RAI1	4.47e-06	179	106	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DOCK3 TET2 TCF4 CEP85L ZFHX4 XIRP2	4.47e-06	179	106	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	normal-na-Myeloid-plasmacytoid_dendritic_cell-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TCF4 ARPP21 COBLL1 DAB2 ITGB4 MYBL2	5.41e-06	185	106	6	3091870a5bf8ecb963e560b47c8502bae367416c
ToppCell	Monocytes-M2-like_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	TCF4 DAB2 SPATS2L PER3 NAV2 TNS1	5.75e-06	187	106	6	59e31c51183ed4c9a3d0792c8005ea3a12b28dfa
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TTC28 ATXN7L1 MACF1 PAN3 MBD5 PDZD2	6.69e-06	192	106	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZBTB33 MAN2A1 HUWE1 TRIM33 USF3 SCAF11	6.89e-06	193	106	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	droplet-Limb_Muscle-MUSCLE-1m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBBP6 C11orf24 NEO1 PER3 MAPK6 TNS1	7.30e-06	195	106	6	fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	SOX5 TTC28 NAV2 PAN3 MBD5 PDZD2	7.52e-06	196	106	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Bronchus_Control_(B.)-Immune-TX-TRAM-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	MIIP RGS19 DAB2 PTK2B MS4A4A ALPK3	7.74e-06	197	106	6	eecb693367510da20a6b1e9355e68785a1e3b85c
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	SOX5 TTC28 NAV2 PAN3 MBD5 PDZD2	7.97e-06	198	106	6	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	FOSL1 MS4A4A USF3 ALPK3 CSPP1	4.30e-05	162	106	5	2f19539c455d1e5d514725845234c7547020e6ad
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DMXL2 HIVEP1 RGS19 DAB2 MS4A4A	5.41e-05	170	106	5	9ac1ef57f14418a5dd2aa16861c3df698c28f5ed
ToppCell	368C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TCF4 COBLL1 CSPP1 ALPK2 MYBL2	5.56e-05	171	106	5	714a0b0d0c9886fef64170cf53eb64f0d8a47280
ToppCell	ICU-SEP-Myeloid-pDC\|ICU-SEP / Disease, Lineage and Cell Type	TCF4 ARPP21 COBLL1 DAB2 MYBL2	5.56e-05	171	106	5	72c448a0dc4c569bd6b465f9aa395f38034e7ea6
ToppCell	Control-B_cell-Plasmablast\|Control / Disease group,lineage and cell class （2021.01.30）	SOX5 TCF4 COBLL1 ZNF827 MYBL2	5.56e-05	171	106	5	c09afc4b111b2b5acca75177554f6364ee02d37c
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 DAB2 ZNF827 MACF1 PAN3	5.87e-05	173	106	5	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 DAB2 ZNF827 MACF1 PAN3	5.87e-05	173	106	5	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TET2 DAB2 ZNF827 MACF1 PAN3	5.87e-05	173	106	5	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	normal_Lymph_Node-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	TCF4 COBLL1 TTLL5 USF3 RAI1	6.04e-05	174	106	5	2274648b80dd74f3c948a779bba3391095964c34
ToppCell	COPD-Myeloid-pDC\|World / Disease state, Lineage and Cell class	TCF4 HIVEP1 ARPP21 COBLL1 MYBL2	6.04e-05	174	106	5	be8227398300711ccda5ecc41ad34064bb246b19
ToppCell	IIF-Myeloid-pDC\|IIF / Disease, Lineage and Cell Type	TCF4 ARPP21 COBLL1 DAB2 MYBL2	6.20e-05	175	106	5	35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc
ToppCell	IPF-Myeloid-pDC\|World / Disease state, Lineage and Cell class	TCF4 HIVEP1 ARPP21 COBLL1 MYBL2	6.20e-05	175	106	5	a06785a4ded01adfd29ca4c20f7759eccbe274cb
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ACRBP GATA2 DAB2 XIRP2 TNS1	6.55e-05	177	106	5	0830944c43de300815831a9e2b2fce40965e7d12
ToppCell	Control-Myeloid-pDC\|Control / Disease state, Lineage and Cell class	TCF4 HIVEP1 ARPP21 COBLL1 MYBL2	6.55e-05	177	106	5	3940663bb5b45b2ca9f772550380a516c53e410b
ToppCell	(9)_Platelet\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ACRBP GATA2 DAB2 XIRP2 TNS1	6.55e-05	177	106	5	e63d01c7fce4fa1256212fa7e95f74281edb3a01
ToppCell	COPD-Myeloid-pDC\|COPD / Disease state, Lineage and Cell class	TCF4 HIVEP1 ARPP21 COBLL1 MYBL2	6.55e-05	177	106	5	415aa023195a7f961c09529f65cdcc7bb90eaf5d
ToppCell	Healthy/Control-pDC\|Healthy/Control / Disease group and Cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	6.72e-05	178	106	5	072b346c6bbd63f00efaceda486400a669b3ec48
ToppCell	IPF-Myeloid-pDC\|IPF / Disease state, Lineage and Cell class	TCF4 HIVEP1 ARPP21 COBLL1 MYBL2	6.72e-05	178	106	5	8d9e28492e1f157bac3308aa947fd864ca16d277
ToppCell	Control-Myeloid-pDC\|World / Disease state, Lineage and Cell class	TCF4 HIVEP1 ARPP21 COBLL1 MYBL2	6.72e-05	178	106	5	20ef63d925e67ddd5955832312ca8574a6f838a4
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B ITGB4 MUC17 MGAM2	6.90e-05	179	106	5	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	COPD-Myeloid-pDC\|Myeloid / Disease state, Lineage and Cell class	TCF4 HIVEP1 ARPP21 COBLL1 MYBL2	6.90e-05	179	106	5	29b058c5e33fda9f0d738c074bdb67ff16b9b6d5
ToppCell	10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages\|lymph-node_spleen / Manually curated celltypes from each tissue	DMXL2 DAB2 MS4A4A ALPK3 TNS1	7.09e-05	180	106	5	7be7d7a6906fff6dbdecd9cb013d855aba4eda2a
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B ITGB4 MUC17 MGAM2	7.09e-05	180	106	5	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B ITGB4 MUC17 MGAM2	7.09e-05	180	106	5	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	3'_v3-Lung-Myeloid_Dendritic-pDC\|Lung / Manually curated celltypes from each tissue	TCF4 ARPP21 COBLL1 TBXT MYBL2	7.27e-05	181	106	5	3d7f089fb434fbc989f1fa159e22133ae00b2487
ToppCell	3'_v3-blood-Myeloid_Dendritic-pDC\|blood / Manually curated celltypes from each tissue	TCF4 HIVEP1 ARPP21 COBLL1 MYBL2	7.27e-05	181	106	5	66d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	MAN2A1 HUWE1 VPS13A CRYBG1 MACF1	7.27e-05	181	106	5	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Healthy/Control-pDC\|World / Disease group and Cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	7.47e-05	182	106	5	97e0eee10905f2cf2bebb09e474629fc224f4397
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TCF4 ARPP21 COBLL1 DAB2 MYBL2	7.47e-05	182	106	5	9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TCF4 ARPP21 COBLL1 DAB2 MYBL2	7.47e-05	182	106	5	4602a98df7045e2c70b7560abfba9b444fbd5d30
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B ITGB4 MUC17 MGAM2	7.66e-05	183	106	5	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 ARPP21 COBLL1 DAB2 MYBL2	7.66e-05	183	106	5	3b123571e10c132227aff65648b4b3c6acb4bd00
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 ARPP21 COBLL1 DAB2 MYBL2	7.66e-05	183	106	5	df6fd0927b6e4cf9a1583969a68096e4bccfbace
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B ITGB4 MUC17 MGAM2	7.86e-05	184	106	5	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 COBLL1 GATA2 SPATS2L CRYBG1	8.06e-05	185	106	5	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	ICU-NoSEP-Myeloid-pDC\|ICU-NoSEP / Disease, Lineage and Cell Type	TCF4 ARPP21 COBLL1 DAB2 MYBL2	8.06e-05	185	106	5	7564a47df4a4e3af30d40aa0f48bd9d9c82358ae
ToppCell	control-Myeloid-pDC\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TCF4 ARPP21 COBLL1 DAB2 MYBL2	8.27e-05	186	106	5	fe31e9cf4575ee40b50489593c51d8c36c3cc532
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SOX5 TCF4 COBLL1 TTLL5 MYBL2	8.27e-05	186	106	5	55b239834b96b1f7787ec77a7d19796d617bbbf0
ToppCell	Multiple_Sclerosis-Myeloid-pDC\|Multiple_Sclerosis / Disease, Lineage and Cell Type	TCF4 ARPP21 COBLL1 DAB2 MYBL2	8.27e-05	186	106	5	330a4f669adea91ff9f2dff2de2210f5e3401e19
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 TCF4 REPS1 RBMS1 SSC5D	8.48e-05	187	106	5	15d6e158562d7d85af3ceaf955439b379c8fce81
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 COBLL1 GATA2 NDST3 CRYBG1	8.48e-05	187	106	5	f6217d0dd425eac76900b44a4e48f45475f3ac36
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 TCF4 REPS1 RBMS1 SSC5D	8.48e-05	187	106	5	f62074b631fd45ad299c69d71b09267b04d656ee
ToppCell	LAM-Lymphoid-pDC\|Lymphoid / Condition, Lineage and Cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	8.48e-05	187	106	5	4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166
ToppCell	control-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	8.48e-05	187	106	5	c78aee98b32719aa45811b620fc97be1ecf5fd53
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 CEP85L TTLL5 ATF7IP GULP1	8.70e-05	188	106	5	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 CEP85L TTLL5 ATF7IP GULP1	8.70e-05	188	106	5	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 CEP85L TTLL5 ATF7IP GULP1	8.70e-05	188	106	5	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 TCF4 REPS1 RBMS1 SSC5D	8.70e-05	188	106	5	32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TTC28 SPATS2L TNS1 ALPK2 GULP1	8.92e-05	189	106	5	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	EYA1 MAST2 XIRP2 ALPK3 ALPK2	8.92e-05	189	106	5	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	EYA1 MAST2 XIRP2 ALPK3 ALPK2	9.14e-05	190	106	5	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	NEO1 SPATS2L NAV2 MACF1 TNS1	9.14e-05	190	106	5	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	TCF4 GSE1 MACF1 MBD5 GULP1	9.14e-05	190	106	5	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COBLL1 GATA2 CRYBG1 MUC6 MGAM2	9.14e-05	190	106	5	078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TCF4 ARPP21 COBLL1 DAB2 MYBL2	9.37e-05	191	106	5	8c487704cbbb5eeff54e8c6fb6fffa1472b5351f
ToppCell	systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	TCF4 ARPP21 COBLL1 DAB2 MYBL2	9.37e-05	191	106	5	78d523f562d32fc408a20d99b0c61cc103241bc0
ToppCell	control-pDC\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	9.84e-05	193	106	5	30a6559c9a9e8941861cb259b4836acccc427e68
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Tuba1c))\|Striatum / BrainAtlas - Mouse McCarroll V32	KIF18A ANKLE1 FOSL1 ATF7IP	9.97e-05	101	106	4	0b32e6071f05dbe808e51e18c3a3f8221f438f83
ToppCell	normal-na-Myeloid-plasmacytoid_dendritic_cell-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TCF4 ARPP21 COBLL1 DAB2 MYBL2	1.01e-04	194	106	5	74545942aded51a0f4ee96054b4ce12c4d99a8a0
ToppCell	Control-Lymphoid-pDC\|Lymphoid / Condition, Lineage and Cell class	TCF4 COBLL1 DAB2 MS4A4A MYBL2	1.01e-04	194	106	5	5f95a5a35f73222dbe2ca52cc580f4774f641403
ToppCell	normal-na-Myeloid-plasmacytoid_dendritic_cell\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TCF4 ARPP21 COBLL1 DAB2 MYBL2	1.01e-04	194	106	5	c25fc353001cdf9fcd772da5a254c857e555eab8
ToppCell	severe-Lymphocytic-Plasmablast\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TCF4 COBLL1 C11orf24 TP73 MYBL2	1.03e-04	195	106	5	43ff1eed563c647bc5b7b06ffe136210653c3a83
ToppCell	mild-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	1.08e-04	197	106	5	0cb00daa6943f7a7fb34a8fdf51188646af65686
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DAB2 MS4A4A SPATS2L RIPOR1 TNS1	1.08e-04	197	106	5	e3349a381723393cd255f202afedd0c99037939b
ToppCell	mild-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 COBLL1 C11orf24 TP73 MYBL2	1.08e-04	197	106	5	21085d5e27b5a23a241a933058bb89f8a1fcf198
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DAB2 MS4A4A SPATS2L RIPOR1 TNS1	1.08e-04	197	106	5	e567886d69c6ea8dec87019c2ebc593793cb3107
ToppCell	mild-pDC\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	1.08e-04	197	106	5	15230a54fa5903dd728de1a0ad633bd2d2c7a04d
ToppCell	severe-pDC\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	1.11e-04	198	106	5	22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK3 DMXL2 ACRBP MS4A4A MUC6	1.11e-04	198	106	5	9430ce7016b1a4724de036aab3e3e4082d24e436
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TCF4 TTC28 GLI3 MACF1 GULP1	1.11e-04	198	106	5	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	severe-pDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 ARPP21 COBLL1 DAB2 MYBL2	1.11e-04	198	106	5	3c4820a8391088682fb3e47b914f872533bae227
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	RBBP6 CNTRL TRIM24 TRIM33 SCAF11	1.11e-04	198	106	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	Sepsis-ICU-SEP-Myeloid-pDC\|ICU-SEP / Disease, condition lineage and cell class	TCF4 COBLL1 DAB2 SSC5D MYBL2	1.11e-04	198	106	5	fe8a68bff8c1b9566eee4bfcab564f206a20ae7b
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TET2 DMXL2 RBBP6 MS4A4A ALPK3	1.14e-04	199	106	5	5b6feacb0ca92c3fc6b327be978320426dcf6f68
ToppCell	Control-Control-Others-RBC\|Control / Disease, condition lineage and cell class	TCF4 COBLL1 DAB2 TNS1 MYBL2	1.14e-04	199	106	5	eb4c52d04f572433c0239bf479d0040a309939a1
ToppCell	severe-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 COBLL1 C11orf24 TP73 MYBL2	1.14e-04	199	106	5	6ee4c2e6049860071169366b7e662d5c1a3cc54b
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EYA1 ITGB4 GLI3 TNS1 TP73	1.14e-04	199	106	5	94a7867e800df352731796de8c24cba133c29622
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	USP36 DMXL2 DAB2 PTK2B MS4A4A	1.14e-04	199	106	5	667b8b47a5b388506e3177b46747267fad8024f6
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TET2 TCF4 COBLL1 ITPRID2 RIF1	1.14e-04	199	106	5	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	TAB2 TRIM24 ZFHX4 GLI3 MYBL2	1.14e-04	199	106	5	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	KIF18A DMXL2 ZBTB33 SPATS2L VPS13A	1.16e-04	200	106	5	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TET2 ATF7IP MACF1 SCAF11 AFF4	1.16e-04	200	106	5	12f1685ce8f218433068e090c9d839cd5a1910bf
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	MIIP RGS19 MLLT10 FOSL1 PER3 GLI3 MARK4 MAPKBP1 CSPP1	2.56e-07	191	105	9	5567_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	TCF4 RBMS1 TRIM24 TRIM33 ZFHX4 ATF7IP GLI3 NAV2	1.29e-06	171	105	8	7535_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	KIF18A DAB2 TRIM24 PIAS1 CREBBP TRIM33 GLI3 NAV2	1.90e-06	180	105	8	4541_DN
Drug	Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A	KIF18A TCF4 RBBP6 DAB2 TRIM24 PIAS1 TRIM33 GSE1	1.98e-06	181	105	8	1791_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	KIF18A HIVEP1 COBLL1 PIAS1 CREBBP TRIM33 ATF7IP	1.64e-05	174	105	7	7530_DN
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	RBMS1 TAB2 PIAS1 CREBBP TRIM33 ATF7IP SCAF11	2.27e-05	183	105	7	7498_DN
Drug	Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A	TCF4 HIVEP1 MUC5B MAST2 PER3 MARK4 CSPP1	2.69e-05	188	105	7	5116_DN
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A	ATXN7L1 GATA2 TAB2 MLLT10 ITGB4 GSE1 MACF1	3.19e-05	193	105	7	6751_DN
Drug	0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A	MUC5B MAST2 VPS13A NAV2 TNS1 MUC6 GULP1	3.19e-05	193	105	7	4712_UP
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A	MIIP DMXL2 COBLL1 TTLL5 MLLT10 ITGB4 TNS1	3.29e-05	194	105	7	2520_DN
Drug	Propofol [2078-54-8]; Down 200; 22.4uM; HL60; HT_HG-U133A	MIIP TCF4 COBLL1 ITGB4 PER3 MARK4 MAPKBP1	3.40e-05	195	105	7	3048_DN
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A	MIIP POM121L2 MLLT10 FOSL1 PTK2B PER3 FAM222B	3.52e-05	196	105	7	2158_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	MIIP TTLL5 GATA2 MLLT10 FOSL1 ZFHX4 TNS1	3.52e-05	196	105	7	6203_DN
Drug	Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; PC3; HT_HG-U133A	MIIP TCF4 RANBP9 PER3 GSE1 CSPP1 TNS1	3.63e-05	197	105	7	6317_DN
Drug	Phensuximide [86-34-0]; Down 200; 21.2uM; PC3; HT_HG-U133A	TCF4 GATA2 MLLT10 MAST2 ITGB4 TRIM33 CSPP1	3.63e-05	197	105	7	5097_DN
Drug	Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	TCF4 ZBTB33 MLLT10 MAST2 TRIM33 MARK4 CSPP1	3.75e-05	198	105	7	5094_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; HL60; HT_HG-U133A	USP36 TCF4 GATA2 MAST2 EPS15L1 MARK4 HTT	3.75e-05	198	105	7	2961_DN
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	TTC28 COBLL1 POM121L2 MLLT10 KSR1 ZFHX4 MARK4	3.87e-05	199	105	7	5358_UP
Drug	Butirosin disulfate salt [51022-98-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	CNTRL DAB2 POM121L2 MUC5B ITGB4 ZFHX4 MUC6	3.87e-05	199	105	7	6080_UP
Drug	Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; HL60; HT_HG-U133A	GATA2 POM121L2 MAST2 ITGB4 EPS15L1 PER3 TNS1	3.87e-05	199	105	7	2147_DN
Drug	Xylazine [7361-61-7]; Down 200; 18.2uM; HL60; HT_HG-U133A	TCF4 TTLL5 POM121L2 MLLT10 FOSL1 MARK4 TNS1	3.87e-05	199	105	7	2132_DN
Drug	Piracetam [7491-74-9]; Down 200; 28.2uM; PC3; HT_HG-U133A	ATXN7L1 GATA2 MLLT10 PER3 MARK4 CSPP1 PDZD2	4.00e-05	200	105	7	5043_DN
Drug	4,4'-oxydianiline	DOCK3 TBXT	6.30e-05	3	105	2	CID000007579
Drug	2,4,4'-trichlorobiphenyl	KIF18A HIVEP1 TTC28 ACRBP RBMS1 TTLL5 CNTRL POM121L2 RFFL ANKLE1 AMER3 PTK2B ZFHX4 NAV2 FRMPD3 CSPP1 RAI1 MYBL2	7.54e-05	1411	105	18	ctd:C081766
Disease	waist-hip ratio	TET2 DMXL2 ARPP21 TTC28 ATXN7L1 RBMS1 COBLL1 DAB2 C11orf24 EYA1 MLLT10 TRIM33 SSC5D GSE1 GLI3 MAPKBP1 HTT TP73	1.71e-07	1226	101	18	EFO_0004343
Disease	C-reactive protein measurement	DOCK3 SOX5 TCF4 DMXL2 ARPP21 COBLL1 MLLT10 FOSL1 MS4A4A NEO1 MARK4 MACF1 SCAF11 MAPK6 BCL2L13 AFF4	3.34e-06	1206	101	16	EFO_0004458
Disease	breast cancer, ovarian carcinoma	TTC28 RANBP9 ADAM29 MLLT10	7.83e-06	37	101	4	EFO_0001075, MONDO_0007254
Disease	monocyte count	TET2 TCF4 HIVEP1 MLLT10 MAST2 FOSL1 PTK2B MS4A4A KSR1 GSE1 MARK4 PAN3 MBD5 BCL2L13 RAI1 MXI1	1.04e-05	1320	101	16	EFO_0005091
Disease	QT interval	CEP85L RFFL EYA1 MAST2 CREBBP SPATS2L ALPK3 HERPUD2 MBD5 RAI1	1.53e-05	534	101	10	EFO_0004682
Disease	myelodysplastic syndrome (implicated_via_orthology)	TET2 CREBBP MYBL2	1.72e-05	15	101	3	DOID:0050908 (implicated_via_orthology)
Disease	sodium measurement	TCF4 ARPP21 MLLT10 MAST2 GSE1	2.85e-05	103	101	5	EFO_0009282
Disease	allergen exposure measurement, FEV/FEC ratio	CEP85L NDST3	3.47e-05	3	101	2	EFO_0004713, EFO_0007944
Disease	breast carcinoma	TET2 TTC28 RBMS1 RANBP9 POM121L2 ADAM29 TAB2 ANKLE1 MLLT10 MAST2 ZNF827 TBXT TNS1	4.52e-05	1019	101	13	EFO_0000305
Disease	neutrophil percentage of leukocytes	TET2 HIVEP1 RBMS1 COBLL1 GATA2 MS4A4A EPS15L1 MARK4 BCL2L13 HTT	4.71e-05	610	101	10	EFO_0007990
Disease	retinal vasculature measurement	SOX5 TCF4 TTLL5 MUC12 PTK2B XIRP2 MUC17 TNS1 PDZD2	7.28e-05	517	101	9	EFO_0010554
Disease	family history of Alzheimer’s disease	PTK2B MS4A4A MARK4 ALPK2	1.05e-04	71	101	4	EFO_0009268
Disease	cognitive function measurement	DOCK3 TCF4 DMXL2 HIVEP1 ARPP21 MAN2A1 TCF20 TTC28 RBMS1 POM121L2 MS4A4A SPATS2L ATF7IP GLI3 CRYBG1	1.08e-04	1434	101	15	EFO_0008354
Disease	Myelodysplastic syndrome	TET2 GATA2	1.15e-04	5	101	2	cv:C3463824
Disease	MYELODYSPLASTIC SYNDROME	TET2 GATA2	1.15e-04	5	101	2	614286
Disease	eosinophil count	DOCK3 TET2 HIVEP1 ATXN7L1 PIAS1 FOSL1 PTK2B EPS15L1 GSE1 ATF7IP MARK4 MBD5 BCL2L13 ALPK2 RAI1	1.62e-04	1488	101	15	EFO_0004842
Disease	worry measurement	TCF4 HIVEP1 ARPP21 NDST3 HTT	1.92e-04	154	101	5	EFO_0009589
Disease	acute myeloid leukemia (is_implicated_in)	TET2 GATA2 MLLT10 CREBBP	2.02e-04	84	101	4	DOID:9119 (is_implicated_in)
Disease	JT interval	CEP85L CREBBP SPATS2L ALPK3 HERPUD2 RAI1	2.16e-04	248	101	6	EFO_0007885
Disease	eosinophil percentage of leukocytes	DOCK3 ATXN7L1 PIAS1 FOSL1 PTK2B EPS15L1 GSE1 MARK4 MBD5 ALPK2	2.44e-04	746	101	10	EFO_0007991
Disease	oppositional defiant disorder measurement	SOX5 HIVEP1 TTLL8	2.56e-04	36	101	3	EFO_0007679
Disease	hypertrophic cardiomyopathy	CEP85L MS4A4A ALPK3 MUC6	2.87e-04	92	101	4	EFO_0000538
Disease	atrial fibrillation	SOX5 CEP85L TAB2 SPATS2L ZFHX4 NAV2 MBD5	2.93e-04	371	101	7	EFO_0000275
Disease	risk-taking behaviour	SOX5 TET2 TCF4 HIVEP1 ARPP21 TCF20 POM121L2 NEO1 SPATS2L HTT	2.94e-04	764	101	10	EFO_0008579
Disease	peak expiratory flow	SOX5 TET2 RBMS1 TAB2 SOX8 NDST3 SPATS2L HERPUD2	3.19e-04	498	101	8	EFO_0009718
Disease	mortality	SOX5 TTC28 SOX8 VPS13A PDZD2	3.29e-04	173	101	5	EFO_0004352
Disease	sexual dimorphism measurement	USP36 DOCK3 SOX5 TET2 COBLL1 POM121L2 EYA1 FOSL1 SSC5D ALPK3 MACF1 MAPKBP1	4.01e-04	1106	101	12	EFO_0021796
Disease	lymphocyte:monocyte ratio	RBMS1 GATA2 EPS15L1 GSE1 MARK4 PAN3	4.79e-04	288	101	6	EFO_0600088
Disease	electrocardiography	SOX5 HIVEP1 CEP85L TAB2 RFFL SPATS2L NAV2 HERPUD2	4.82e-04	530	101	8	EFO_0004327
Disease	household income	TET2 TCF4 SPATS2L ATF7IP HTT GULP1	6.36e-04	304	101	6	EFO_0009695
Disease	cortical surface area measurement	SOX5 TET2 TCF4 REPS1 EYA1 MAST2 NEO1 GLI3 NAV2 MACF1 MAPK6 TNS1 PDZD2	6.79e-04	1345	101	13	EFO_0010736
Disease	cup-to-disc ratio measurement	TTC28 GATA2 EYA1 GLI3 NAV2 MXI1 PDZD2	7.05e-04	430	101	7	EFO_0006939
Disease	neuroticism measurement, cognitive function measurement	SOX5 TET2 HIVEP1 RBMS1 MLLT10 SYNGAP1 NAV2 RAI1	7.40e-04	566	101	8	EFO_0007660, EFO_0008354
Disease	acute myeloid leukemia (implicated_via_orthology)	CREBBP MYBL2	7.49e-04	12	101	2	DOID:9119 (implicated_via_orthology)
Disease	Alzheimer disease, family history of Alzheimer’s disease	PTK2B MS4A4A MARK4 ALPK2	7.60e-04	119	101	4	EFO_0009268, MONDO_0004975
Disease	neutrophil count	TET2 HIVEP1 TTC28 RBMS1 GATA2 MAST2 CREBBP TRIM33 EPS15L1 MARK4 BCL2L13 HTT MXI1	8.71e-04	1382	101	13	EFO_0004833
Disease	loneliness measurement	TCF4 HIVEP1 MACF1 MBD5	8.86e-04	124	101	4	EFO_0007865
Disease	chronotype measurement	DOCK3 SOX5 TCF4 HIVEP1 TCF20 TTC28 RBBP6 SYNGAP1 TRIM33 PER3	8.95e-04	882	101	10	EFO_0008328
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	ACRBP TTLL5 MS4A4A HERPUD2	1.09e-03	131	101	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	ACRBP TTLL5 MS4A4A HERPUD2	1.09e-03	131	101	4	C4552091
Disease	Juvenile arthritis	ACRBP TTLL5 MS4A4A HERPUD2	1.09e-03	131	101	4	C3495559
Disease	Juvenile psoriatic arthritis	ACRBP TTLL5 MS4A4A HERPUD2	1.09e-03	131	101	4	C3714758
Disease	neuroimaging measurement	SOX5 TCF4 MLLT10 NEO1 GLI3 NAV2 MACF1 MAPK6 TNS1 RAI1 HTT	1.09e-03	1069	101	11	EFO_0004346
Disease	insulin resistance	USP36 COBLL1 EYA1	1.10e-03	59	101	3	EFO_0002614
Disease	asthma	USP36 DOCK3 DMXL2 HIVEP1 MUC16 FOSL1 EPS15L1 GLI3 TBXT	1.11e-03	751	101	9	MONDO_0004979
Disease	hepcidin:transferrin saturation ratio	MUC16 PAN3	1.18e-03	15	101	2	EFO_0007902
Disease	uric acid measurement	SOX5 TET2 TCF4 RBMS1 COBLL1 ZNF827 MARK4 TBXT	1.20e-03	610	101	8	EFO_0004761
Disease	Juvenile-Onset Still Disease	ACRBP TTLL5 MS4A4A HERPUD2	1.21e-03	135	101	4	C0087031
Disease	sleep measurement	SOX5 TET2 EYA1 NDST3	1.21e-03	135	101	4	EFO_0004870
Disease	body weight	SOX5 TET2 HIVEP1 RBMS1 DAB2 POM121L2 HUWE1 MLLT10 TRIM24 USF3 GSE1 PDZD2	1.26e-03	1261	101	12	EFO_0004338
Disease	chronic kidney disease	ATXN7L1 RGS19 DAB2 NDST3 MUC17	1.31e-03	235	101	5	EFO_0003884
Disease	testosterone measurement	DOCK3 SOX5 TET2 KIF18A TTC28 COBLL1 EYA1 PER3 ZFHX4 MACF1 RAI1 MXI1	1.38e-03	1275	101	12	EFO_0004908
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC6	1.39e-03	64	101	3	DOID:4947 (is_marker_for)
Disease	myeloid white cell count	TET2 TCF4 TTC28 MAST2 PTK2B EPS15L1 MARK4 BCL2L13 HTT MXI1	1.41e-03	937	101	10	EFO_0007988
Disease	mean corpuscular hemoglobin concentration	SOX5 TTC28 COBLL1 TRIM33 RIF1 NEO1 FAM222B VPS13A MACF1 PAN3 MXI1	1.42e-03	1105	101	11	EFO_0004528
Disease	stomach cancer (is_marker_for)	TET2 KIF18A GSE1 TP73	1.46e-03	142	101	4	DOID:10534 (is_marker_for)
Disease	body fat percentage	DMXL2 HIVEP1 COBLL1 MLLT10 PIAS1 MACF1 HTT	1.47e-03	488	101	7	EFO_0007800
Disease	lymphocyte count	TET2 TCF4 HIVEP1 TTC28 RGS19 RBMS1 COBLL1 GATA2 EPS15L1 MARK4 RIPOR1 RAI1 HTT	1.47e-03	1464	101	13	EFO_0004587
Disease	cortical thickness	SOX5 TCF4 EYA1 MLLT10 MAST2 NEO1 GLI3 NAV2 MACF1 TNS1 PDZD2	1.50e-03	1113	101	11	EFO_0004840
Disease	Acute myeloid leukemia	GATA2 MLLT10	1.53e-03	17	101	2	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	GATA2 MLLT10	1.53e-03	17	101	2	601626
Disease	platelet-to-lymphocyte ratio	TTC28 RBMS1 PWWP2A EPS15L1 MARK4 RAI1	1.58e-03	363	101	6	EFO_0008446
Disease	Alzheimer disease, educational attainment	DOCK3 TET2 PTK2B ATF7IP MARK4	1.63e-03	247	101	5	EFO_0011015, MONDO_0004975
Disease	synophrys measurement	ZFHX4 NAV2 HTT	1.66e-03	68	101	3	EFO_0007906
Disease	hemorrhoid	SOX5 TET2 MUC12 PIAS1	1.66e-03	147	101	4	EFO_0009552
Disease	gait measurement	TCF4 POM121L2 MLLT10 HTT	1.79e-03	150	101	4	EFO_0007680
Disease	autism spectrum disorder (implicated_via_orthology)	TCF20 CREBBP SYNGAP1 NDST3	1.88e-03	152	101	4	DOID:0060041 (implicated_via_orthology)
Disease	reaction time measurement	SOX5 TET2 REPS1 TTC28 TNRC6C SPATS2L NAV2 RAI1	1.92e-03	658	101	8	EFO_0008393
Disease	stomach cancer (is_implicated_in)	TET2 FOSL1 GSE1	1.96e-03	72	101	3	DOID:10534 (is_implicated_in)
Disease	glucose measurement	SOX5 TET2 RBMS1 COBLL1 SYNGAP1 GLI3	1.99e-03	380	101	6	EFO_0004468
Disease	pentachlorophenol measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022071
Disease	parathion measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022070
Disease	potassium chromate measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022072
Disease	mercuric chloride measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022068
Disease	heptachlor epoxide measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022067
Disease	methoxychlor measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022052
Disease	azinphos methyl measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022055
Disease	aldrin measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022054
Disease	dicofol measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022060
Disease	disulfoton measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022062
Disease	dieldrin measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022061
Disease	endrin measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022064
Disease	endosulfan measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022063
Disease	heptachlor measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022066
Disease	ethion measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022065
Disease	chlorpyrifos measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022057
Disease	cadmium chloride measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022056
Disease	diazinon measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022059
Disease	dibutyl phthalate measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0022058
Disease	environmental exposure measurement	MUC16 SPATS2L TNS1	2.03e-03	73	101	3	EFO_0008360
Disease	lymphocyte percentage of leukocytes	TET2 HIVEP1 TTC28 RBMS1 GATA2 EPS15L1 MARK4 BCL2L13	2.05e-03	665	101	8	EFO_0007993
Disease	Craniofacial Abnormalities	TCF4 GATA2 EYA1 RAI1	2.06e-03	156	101	4	C0376634
Disease	Paroxysmal atrial fibrillation	SOX5 SPATS2L NAV2 MBD5	2.06e-03	156	101	4	C0235480
Disease	familial atrial fibrillation	SOX5 SPATS2L NAV2 MBD5	2.06e-03	156	101	4	C3468561
Disease	Persistent atrial fibrillation	SOX5 SPATS2L NAV2 MBD5	2.06e-03	156	101	4	C2585653
Disease	hemoglobin A1 measurement	TET2 TCF4 COBLL1 MAST2 VPS13A MACF1 GULP1	2.10e-03	520	101	7	EFO_0007629
Disease	DDT metabolite measurement	MUC16 SPATS2L TNS1	2.12e-03	74	101	3	EFO_0007886
Disease	Atrial Fibrillation	SOX5 SPATS2L NAV2 MBD5	2.26e-03	160	101	4	C0004238

Protein segments in the cluster

Peptide	Gene	Start	Entry
HTSPVFSPANPESSM	BCL2L13	86	Q9BXK5
QSSSSPSMTTIHGLP	AMER3	721	Q8N944
VMPSQSHPQLTPSQS	ADAM29	781	Q9UKF5
TSSPLMVTPPSAEAH	EPS15L1	106	Q9UBC2
PSSSHSPIPSSMSNM	CNTRL	16	Q7Z7A1
MPPPPSSKVSSHSSQ	CNTRL	1146	Q7Z7A1
SPSSMPLLDRSPAHS	ANKLE1	291	Q8NAG6
SGSPPATVSNAPHVM	ADGRG4	2016	Q8IZF6
SPTSPLSSCLPIMTH	ALPK2	1536	Q86TB3
PTTMTSPISPHFTVT	ACRBP	146	Q8NEB7
TNHSSPASTPKRVPM	GSE1	91	Q14687
PTQSHPPETMATSSE	ALPK3	1121	Q96L96
STAAGMPSLQHTTPP	CREBBP	861	Q92793
PETSPSVSPMPHSSS	DMXL2	946	Q8TDJ6
SVSPMPHSSSIANLQ	DMXL2	951	Q8TDJ6
SPEQTLSPLSKMPHS	COBLL1	911	Q53SF7
GPHCPSSTVPVMSAS	ARPP21	781	Q9UBL0
SPDPSALMSHTTAFP	ATXN7L1	571	Q9ULK2
TMPRSTPGSNSEPSH	AFF4	401	Q9UHB7
PNTMATTHGRSLPPS	MUC5B	2191	Q9HC84
GHCPSTPATSSTAMP	MUC5B	4226	Q9HC84
VMHPSILSNSPSPKT	NDST3	616	O95803
VSPRPFSSPSMSPSH	RANBP9	476	Q96S59
HFMPLLNPSPTDATS	RAI1	391	Q7Z5J4
AHPMAPPSPSTTSSN	RBMS1	31	P29558
APAVSTQPPSMHSSL	DAB2	601	P98082
SSALTPQMTATHPPS	MUC16	1126	Q8WXI7
TSASIHSMPTGTIPP	MUC6	1641	Q6W4X9
TGSTHTAPPMTPTTS	MUC6	1886	Q6W4X9
SPIPPLHMTSALSSS	GLI3	151	P10071
PSSLSLMHSPPGTQN	MAN2A1	1111	Q16706
TPTKTSTIPMSSHPS	MGAM2	1816	Q2M2H8
STIPMSSHPSPSTTN	MGAM2	1821	Q2M2H8
PPNVSSSLPNHMPSS	ZBTB33	291	Q86T24
DPSSFSTKHSMPVPS	KIF18A	801	Q8NI77
PSHSSADINSSLPPM	TCF4	266	P15884
SSPHTSSPTFPPAAM	PER3	776	P56645
PMKNPSHPTASALST	PER3	996	P56645
SHPTASALSTGSPPM	PER3	1001	P56645
SALSTGSPPMKNPSH	PER3	1006	P56645
PPAMNHLDSSSNPSS	KSR1	436	Q8IVT5
TLTPSAMKSSPQIPH	MAPK6	696	Q16659
PSLTPCSTPTHMSRS	PDZD2	676	O15018
HESSMSRAQSPPVPA	CSPP1	911	Q1MSJ5
ASTRVSTHSVPTPMP	FAM222B	306	Q8WU58
STHSVPTPMPSCVVN	FAM222B	311	Q8WU58
PAHYMTSSNTSPTTP	EYA1	236	Q99502
TSETMPPPSQTALTH	DEFB125	141	Q8N687
SREPSSMHISSSLPP	HUWE1	3936	Q7Z6Z7
PPPMSQSTCSLHSIH	ITPRID2	836	P28290
SFTSQMLSSQPPPHG	ITGB4	1111	P16144
SNHSCTSMPSSPATP	MACF1	7241	Q9UPN3
QDPLMIPVTSSSTHP	RBBP6	366	Q7Z6E9
SHTPNPASYMVPSSA	PAN3	361	Q58A45
SAQSMVSGSHCTPPP	TP73	471	O15350
PSSSLSFGHPHPSSM	GATA2	461	P23769
TMQDSLSPSPPVSSH	HTT	2066	P42858
SSTHSAPSQMITSAP	DOCK3	1746	Q8IZD9
MPVSSHTPPGTQTNT	LINC01599	296	Q8WXQ3
EHPPGSPTSATVMST	FRMPD3	1786	Q5JV73
PFSPISHQSSMPTRN	GULP1	221	Q9UBP9
TLPTAHVMPSNSSAS	CEP85L	96	Q5SZL2
NHTPVSTMSSSQPVS	ATF7IP	986	Q6VMQ6
LPSHSHMAETASPTP	MS4A4A	221	Q96JQ5
PSSPMVSSAHNPNKA	MARK4	471	Q96L34
PSEHHTCSPLASPMS	MAST2	1061	Q6P0Q8
TCSPLASPMSPHSQS	MAST2	1066	Q6P0Q8
ASPMSPHSQSSNPSS	MAST2	1071	Q6P0Q8
PSRPHSYQNPTTSSM	MAPKBP1	1241	O60336
STSLSPSPVTSPVHM	MBD5	431	Q9P267
RPSMPSSPSTKSDGH	MBD5	501	Q9P267
MVHLVCTSRTPPSSP	HERPUD2	81	Q9BSE4
PTAMPKPQHTFSDSQ	CRYBG1	441	Q9Y4K1
TSPMEYPSPVNSLHT	PTK2B	751	Q14289
SSSHVSNNMSTPVLP	SCAF11	1306	Q99590
HTPTLMTTPSLTPFT	FOSL1	216	P15407
SPSSPHMPESDTLST	OR1C1	261	Q15619
PLTSMPVNHTPVASS	MUC17	2811	Q685J3
PSMSSHDTASPAAPS	RGS19	21	P49795
FPPGSMHAPSTSSTS	PWWP2A	606	Q96N64
HNTTINPTSPTTATM	TRIM33	636	Q9UPN9
THPNSMDNLPSAASP	TNRC6C	1301	Q9HCJ0
TPPTSTLLTMHPASV	REPS1	236	Q96D71
LPSTADPSHQTMPAN	SPATS2L	411	Q9NUQ6
SHVYMPISSPTTSQP	TAB2	281	Q9NYJ8
HSSMVPPTSPNLPSS	RFFL	166	Q8WZ73
SCHVATSPGLNPMTP	RIF1	381	Q5UIP0
SMDNTPHTPTPFKNA	MYBL2	511	P10244
LSGTSSPFHPASPMQ	MIIP	351	Q5JXC2
SPHGSPTSPLDSNML	NEO1	1091	Q92859
MTDSSLPSSPKLPHN	NAV2	1861	Q8IVL1
PPCSPSGTASSMSHV	SOX8	11	P57073
TPADLSIPNVHSSPM	PIAS1	71	O75925
SIPNVHSSPMPATLS	PIAS1	76	O75925
PTTTPHPTTITHSTM	SSC5D	1181	A1L4H1
HPTTITHSTMIPDPT	SSC5D	1186	A1L4H1
TTMQPTTTPHSTTPH	SSC5D	1226	A1L4H1
PTTTPHPTTITHSTM	SSC5D	1241	A1L4H1
HPTTITHSTMIPDPT	SSC5D	1246	A1L4H1
MVSSPTSHLSASAPP	POM121L2	511	Q96KW2
PTFPQLTASPHSMDS	ARNTL	451	O00327
NATHPMPATLTNSAS	MLLT10	941	P55197
PSPSKHMPSDTAASP	C11orf24	231	Q96F05
TQSSKPSPTQHPVSM	XIRP2	1981	A4UGR9
MTSVHPPIRSPSASS	TRIM24	676	O15164
LTQMPPQASSSHTTA	ZFHX4	2511	Q86UP3
INSSPTMHPSTPVTA	TTLL8	541	A6PVC2
NTFHMITESQSSPPP	VPS13A	1241	Q96RL7
ESPSSMQPQPLETSH	ZSCAN21	156	Q9Y5A6
QHSQTPSTLNPTMPA	SYNGAP1	1136	Q96PV0
NPSMAAPSSPSLSHH	TNS1	1201	Q9HBL0
MTPCVTNIPHSSSAT	USF3	296	Q68DE3
MLPVSHNASPPTSSS	TBXT	331	O15178
PASSSSHLQPMQRPS	TCF20	201	Q9UGU0
HPPPASSFLSLASMT	ZNF827	271	Q17R98
KSPRNMSPSSGHQSP	TTC28	2301	Q96AY4
MPSPHLPSEHSSVSS	SOX5	686	P35711
IGPVQTTTSPTHTMP	RIPOR1	596	Q6ZS17
TTTSPTHTMPSPTHT	RIPOR1	601	Q6ZS17
THTMPSPTHTTASPT	RIPOR1	606	Q6ZS17
PTHTPTSPTHKTSMS	RIPOR1	626	Q6ZS17
TSPTHKTSMSPPTTT	RIPOR1	631	Q6ZS17
QSPNPSTHVCSPSPM	TET2	461	Q6N021
STHVCSPSPMLSERP	TET2	466	Q6N021
SPQTAAGMPSVASPH	HIVEP1	2341	P15822
SGSPSPKLSQTPTHM	USP36	511	Q9P275
PPSPSSDLTHPMKTS	USP36	711	Q9P275
SSLSQIPSAIPSMPH	TTLL5	916	Q6EMB2
SSPRSPDTTHLPASM	MUC12	641	Q9UKN1
ASSFPSMPSPRLQHS	MXI1	31	P50539